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Abstract Given their totipotency, human embryonic stem
cells (hESCs) can differentiate into all types of cells, including
adipocytes, and provide an excellent researchmodel for study-
ing diseases associated with the metabolism of adipocytes,
such as obesity and diabetes mellitus. Epigenetic regulation,
including DNA methylation and histone modification, plays
an essential role in the development and differentiation of
hESCs. Lysine-specific demethylase 1 (LSD1), a well-
characterized histone-modifying enzyme, demethylates
dimethylated histone H3 lysine 4 (H3K4) through a flavin
adenine dinucleotide (FAD)-dependent oxidative reaction.
LSD1 affects the growth and differentiation of human and
mouse ES cells, and the deletion of this gene in mice leads
to embryonic lethality. Here, we investigated the functional
role of LSD1 during the adipogenic differentiation of hESCs
involving the demethylation of H3K4. We also found that
treating hESCs with the LSD1 inhibitor CBB1007 promotes
the adipogenic differentiation of hESCs.
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Introduction
In 1998, human embryonic stem cells (hESCs) were first iso-
lated by Thomson et al. [1] and have become a potential
source for cell replacement therapies because of their abilities
to self-renew and maintain pluripotency with the potential to
differentiate into all types of cells. The epigenetic modifica-
tion of chromosomes plays an important role in ES cell main-
tenance and differentiation [2]. An important aspect of epige-
netic regulation is posttranslational histone tail modification,
including acetylation, methylation, citrullination, phosphory-
lation, ubiquitylation, sumoylation, and biotinylation [3].
Among these modifications, methylation marks are dynami-
cally regulated by histone methyltransferases and
demethylases [4]. Several studies have reported the role of
the dynamic regulation of histone tail methylation in the main-
tenance of pluripotency in stem cells to block cell differentia-
tion [5, 6]. Histone demethylases have also been reported to be
associated with a broad spectrum of developmental functions
in gametogenesis, embryogenesis and differentiation [7, 8].
Lysine-specific demethylase 1 (LSD1/KDM1A) [9] is a
flavin-containing amino oxidase (AO) that mainly
demethylates dimethylated histone H3 lysine 4 (H3K4)
through a flavin adenine dinucleotide (FAD)-dependent oxi-
dative reaction but does not alter trimethylated H3K4 [10, 11].
Although LSD1 is important for maintaining the pluripotency
of ES cells [12–14] and the knockdown of LSD1 results in
decreased differentiation of lineage-committed 3 T3-L1
preadipocytes into adipocytes [15], the role of LSD1 in induc-
ing adipogenesis from hESCs has not been explored. Various
LSD1 inhibitors have been discovered, and their inhibitory
efficiencies have been reported [16, 17]. CBB1007 is one of
several competitive LSD1 inhibitors that were developed
based on the structure of LSD1 with a peptide inhibitor de-
rived from the N-terminal tail of histone H3 [18] that can
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efficiently inhibit the LSD1-mediated demethylation of
H3K4me2 [19]. Here, we explored the role and mechanism
of LSD1 in induced adipogenesis of hESCs using the LSD1




The classical human embryonic stem cell line H9 was kindly
provided by the National StemCell Bank c/oWiCell Research
Institute [1] and was routinely propagated on a feeder layer
composed of inactivated mouse embryonic fibroblast (MEF)
[20]. The cultures were maintained in an incubator at 37 °C
with a humidified atmosphere of 5 % CO2 in air. MEFs sep-
arated from ICR fetal mice at gestation day 12.5 were pur-
chased from Beijing Weitong Lihua Experimental Animal
Technology Co. Ltd. The hESCs were incubated on an
inactivated feeder layer. Primary MEFs from passages 1 to 4
were inactivated with mitomycin C to prepare the feeder layer.
One passage of hESCs was performed using the mechanical
method every 5 to 7 days. The hESC culture medium
contained 80 % Dulbecco’s modified Eagle medium
(DMEM/F12 (Invitrogen; 11330–032), 20 % knockout serum
replacement (Invitrogen; 10828–028), 2 mM GlutaMAX
(Invitrogen; 25030–081), 1 % nonessential amino acids
(NEAAs) (Invitrogen; 11140), 0.25 % 55 mM 2-
mercaptoethanol (Invitrogen; 21985), and 4 ng/mL basic fi-
broblast growth factor (bFGF) (Invitrogen; 13256).
Adipogenic Differentiation and LSD1 Inhibitor Treatment
H9 cells were differentiated into adipocytes directly by chang-
ing the normal culture medium to an adipogenic differentia-
tion cocktail, which consisted of 90 % α–MEM, 10 % knock-
out serum replacement, 10 μg/mL insulin, 0.5 mmol/L 3-
isobutyl-1-methylxanthine (IBMX), 10 μmol/L rosiglitazone
and 1 μmol/L dexamethasone. The adipogenic induction cul-
ture lasted for 14 days with daily medium changes, and the
cell colonies were then observed under an inverted micro-
scope. CBB1007 (Millipore, Billerica, MA, USA) at concen-
trations of 5 mM,10 mM and 20 mM was added to the
adipogenic induction medium as the experimental groups
from day 1 to day 14 of induction. In contrast, CBB1007
was not added to the control group.
Oil Red O Staining
After the removal of the medium, differentiated hESCs on day
14 were washed twice with PBS, fixed with 10 % paraformal-
dehyde for 30min, and then stained with diluted Oil Red O for
10min at room temperature. The cells were washedwith 75%
alcohol to remove the unbound dyes and stained with hema-
toxylin for 1 min. After washing with PBS, the cells were
observed under an inverted microscope.
RNA Extraction and Real-Time Polymerase Chain
Reaction (RT-PCR)
The total cellular RNA from undifferentiated hESCs cultured
in proliferation medium and from hESCs cultured in differen-
tiation medium for 14 days was extracted using the RNeasy
plus mini kit (Qiagen 74134) according to the suggestions
provided by the supplier. For real-time polymerase chain re-
action (RT-PCR), cDNA was synthesized using iScript
(BIORAD). RT-PCR was performed on an Applied
Biosystems 7500 Real-Time PCR System equipped with a
96-well reaction plate. Relative quantification of the mRNA
levels was performed using the comparative cycle threshold
(Ct) method using β-actin as the reference gene. The primers
used for RT-PCR are listed in Table 1.
Protein Extraction and Western Blotting Detection
After washing twice with PBS, the undifferentiated and dif-
ferentiated cells were harvested by the addition of ice-cold cell
lysis buffer (Cell Signaling; #9803) and a protease inhibitor-
phenylmethanesulfonyl fluoride (PMSF) (Cell Signaling;
#8553) mixture into the culture system. Fifty micrograms of
protein extracts were resolved by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) and electrotransferred onto
polyvinylidene difluoride membranes. The membranes were
blocked for 2 h at room temperature with 5 % nonfat dry milk
in Tris-buffered saline and then stored in a box with the pri-
mary antibodies, which were diluted in 5 % nonfat milk/Tris-
buffered saline, overnight with shaking at 4 °C. Subsequently,
the membranes were washed thrice with TBS-T and then in-
cubated with a horseradish peroxidase-conjugated secondary
antibody with shaking for 1.5 h at 37 °C. The probed mem-
branes were then incubated in 2 mL of ECL detection reagent
for 4 min and subjected to image detection in a darkroom.
Table 1 Target gene primers used in the RT-qPCR analysis
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GAPDH served as the control. The film was scanned accord-
ing to the manufacturer’s suggestion, and a gel imaging sys-
tem and an image analysis software were used to analyze the
results. Anti-histone H3 peptide with dimethylated lysine 4
(H3K4me2; ab32356), anti-histone H3 (ab61251) and LSD1
(ab129195) antibodies were from Abcam.
Statistical Analysis
Two-tailed Student’s t-test was used to compare the average
values between two groups, and analysis of variance
(ANOVA) was conducted for multiple comparisons. These
tests were performed using SPSS version 20.0. All of the
values are shown as the means± standard deviations (SDs).
P-values less than 0.05 were considered to be statistically
significant.
Results
Adipogenic Differentiation of hESCs in Vitro
The human embryonic stem cell line H9 was differentiated
into adipocytes by directly adding adipogenic medium cock-
tail into the culture system for 14 days. Before induction, we
chose H9 colonies with an undifferentiated status that had flat,
elliptically shaped and clear, smooth cell boundaries (Fig. 1a).
After 1 day of induction, the shape and boundaries of the
colonies changed to have an irregular edge, signs of apoptosis
were noted in cells on the top of the colonies and the colonies
became loose. On subsequent days, the colonies became loos-
er, and more cells underwent apoptosis mainly on the top and
near the edge. The shape of the cells also clearly changed. On
day 14 of induction, the colonies only had one layer of cells
remaining. The morphology of the cells changed from round
to irregular, and the colonies became larger (Fig. 1b). And
then the Oil Red O staining was used to identify that the
adipogenesis was successful (Fig. 1c).
After 7 days of induction, the cell colonies exhibited lipid
accumulation, as determined by Oil Red O staining, although
the lipid droplets in the different groups appeared to have
different densities. However, after 14 days of induction, more
prominent lipid droplets were shown by Oil Red O staining
under the microscope. Additionally, the expression of a set of
adipocyte markers, including peroxisome proliferator-
activated receptor γ-2 (PPARγ-2) and CCAAT/enhancer-
binding protein (C/EBP) α, was detected through RT-qPCR
analysis. We found that PPARγ-2 and C/EBPα were
expressed in differentiated cells but not in undifferentiated
cells, demonstrating that adipogenic differentiation from
hESCs was successful.
The LSD1 Inhibitor CBB1007 Promotes the Adipogenic
Differentiation of hESCs
According to the dose of the LSD1 inhibitor CBB1007 that
was added to the induction medium cocktail, the cultures were
divided into 5 groups: control group, 5-μM group, 10-μM
group, and 20-μM group. After 14 days of induction, all of
the groups were processed by Oil Red O staining to detect
adipocyte accumulation. Additionally, as the dose of
CBB1007 increased, the density of the lipid droplets
Fig. 1 Adipogenic differentiation of hESCs in vitro. a. Undifferentiated
status of H9 colonies that were chosen to undergo adipogenic
differentiation. The colonies appeared flat and elliptical in shape and
exhibited clear, smooth cell boundaries. b. The morphology of the
colonies after day 14 of induction. Only one layer of cells remained.
The shape of the cells changed from round to irregular. Additionally,
the colonies extended out to become larger. c. Oil Red O staining on
day 14 after induction. The lipid droplets were stained with red and
showed that the adipogenesis was successful. Scale bar = 20 μm
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increased. The color of the lipid droplets was red, and some of
the droplets fused together due to their high density (Fig. 2a).
Additionally, the RT-qPCR results indicated that PPARγ-2
and C/EBPα expression increased with increasing doses of
CBB1007 (Fig. 2b-c). By comparing the Oil Red O staining
and RT-qPCR results between the groups, we noted that the
efficiency of the adipogenic differentiation of hESCs in-
creased as the dose of the LSD1 inhibitor CBB1007 increased.
The LSD1 Inhibitor CBB1007 Increased H3K4me2 Levels
To investigate the role of LSD1 in the induced differentiation
of adipocytes, a western blotting analysis was performed to
detect the expression of LSD1, histone H3 and H3K4me2 in
every group on day 14 of differentiation (Fig. 3a). After
14 days of induction, the expression levels of LSD1 and his-
toneH3 decreased from the control group to the 20-μMgroup,
whereas the level of histone H3K4 dimethylation (H3K4me2)
increased with increasing doses of CBB1007. GAPDH was
used as the internal standard.
Additionally, densitometry analysis of the bands from the
phosphorylated forms of LSD1, histone H3 and H3K4me2
was performed to analyze the relative expression level. With
increasing CBB1007 doses, the levels of LSD1 and histone
H3maintained the same expression tendency—i.e., LSD1 and
histone H3 decreased together on day 14. However, because
of the demethylation role of LSD1, H3K4me2 exhibited the
opposite tendency compared with LSD1 (Fig. 3b).
Discussion
This study is the first to study the role of LSD1 in the induc-
tion of adipogenic differentiation in hESCs. By adding
CBB1007 during differentiation, we found that inhibition of
the lysine specific demethylase-1 LSD1 promotes adipogenic
differentiation from hESCs through H3K4 methylation.
Here, we used an adipogenic cocktail that included insulin,
dexamethasone, 3-isobutyl-1-methylxanthine (IBMX) and
rosiglitazone to induce the differentiation of hESCs into adi-
pocytes. Insulin is the most important part of the cocktail.
Insulin plays an important role in glucose transport, glycemic
control and glycogen synthesis. Insulin helps adipocytes
transport glucose by binding to insulin receptors on the
Fig. 2 The LSD1 inhibitor CBB1007 promotes the adipogenic
differentiation of hESCs. a. Oil Red O staining on day 14 after
induction. After 14 days of induction, as the dose of CBB1007
increased, the density of the lipid droplets increased. The color of the
lipid droplets was red, and some of the droplets fused together due to
the high density. Scale bar = 20 μm. b. C. qRT-PCR analysis of the
relative gene expression of a set of adipocyte markers, PPARγ-2 and C/
EBPα, on day 14 after induction. The bars indicate the standard error of
the mean (SEM) of the two genes. The results of the experiments were
independently confirmed three times. The error bars represent SEMs for
duplicate samples. The significant differences were analyzed by one-way
ANOVA. ∗, P< 0.05
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surface of the adipocyte membrane. Thus, insulin enhanced
the activation of lipoprotein lipase and promoted the synthesis
of adipocytes. Additionally, insulin at concentrations higher
than physiological doses can improve preadipocyte prolifera-
tion by acting on insulin-like growth factor-1 [21].
Dexamethasone induces the expression of C/EBPα and
PPARγ and activates these proteins by increasing the expres-
sion of EEAAT/enhancer-binding protein δ (C/EBP δ) and
forming a complex with C/EBP δ, resulting in the acceleration
of the efficiency of adipocyte differentiation [22]. IBMX re-
presses the activation of cyclic adenosine monophosphate
(cAMP) phosphodiesterase and increases the activation of
adenylate cyclase, resulting in increased cAMP expression.
Additionally, cAMP reacts with cAMP response elements in
the cell nucleus by activating cAMP response element binding
protein, thus leading to induced expression of adipogenic
genes, such as C/EBPβ [23]. Rosiglitazone, a member of the
thiazolidinedione (TZD) class of medicinal drugs, can highly
selectively activate PPARγ receptors, resulting in highly effi-
cient adipocyte synthesis and retention. In the early phase of
preadipocyte differentiation, adipogenic stimuli induce low-
level PPARγ and C/EBPα expression. Subsequently, these
proteins promote each other’s expression to form a positive
feedback loop. The resulting high levels of PPARγ and C/
EBPα activate adipocyte gene expression and thereby lipid
accumulation, ultimately leading to the phenotypic conversion
of hESCs to adipocytes [24].
LSD1 is a novel regulator of lipid metabolism [25]. In our
study, we first hypothesized that LSD1 promotes or inhibits
the induced differentiation of hESCs because it has been re-
ported that its action is irreplaceable at phenotypic switch
points at multiple stages of stem cell development, such as
adipogenesis [26]. High expression levels of LSD1 are critical
for maintaining hESCs in an undifferentiated status and lead
to embryonic lethality in knockout mice [13, 27]. The knock-
down of LSD1 in a mouse cell culture model also prevented
the epithelial-to-mesenchymal transition [28]. However, we
demonstrated that the inhibitor LSD1 promotes adipocyte dif-
ferentiation from hESCs.
In our study, CBB1007, an inhibitor of LSD1, was used to
assess the role of LSD1 in the adipogenic differentiation from
hESCs. Next, we demonstrated that the amidino-guanidinium
compound that acts as a reversible and substrate competitive
LSD1-selective inhibitor [18] could dramatically suppress the
expression of LSD1 but enhance H3K4 methylation, thus ef-
fectively promoting the adipogenic differentiation of hESCs.
In general, LSD1 is enriched at core promoter regions and
enhancers of embryonic stem cells, as detected by chromatin
immunoprecipitation (ChIP)-sequencing analysis [14, 29].
LSD1 acts as a transcriptional repressor and is a component
of various transcriptional corepressor complexes [5, 30–33],
whereas histone H3K4 methylation is generally associated
with gene activation and the upregulation of transcription
through the recruitment of nucleosome remodeling enzymes
and histone acetylates [34]. H3K4 dimethylation is observed
on the transcription factors PPARγ and C/EBPα, both of
which are the master regulators of adipogenesis [15]. The
latter finding indicates that the inhibition of histone
demethylase LSD1 increases histone H3K4 dimethylation
(H3K4me2) on the PPARγ and C/EBPα promoters, facilitat-
ing the expression of PPARγ and C/EBPα and leading to
increased adipogenesis.
In this regard, we provide the first demonstration of an as-
sociation between the H3K4 histone demethylase LSD1 and
the induced differentiation of adipocytes from hESCs. In the
control group, the expression of LSD1 increased on day 14 of
induction compared with day 0. However, after inhibition by
CBB1007, the expression of LSD1was sharply repressed. As a
result, the efficiency of adipogenesis increased as shown by Oil
Red O staining and PPARγ and C/EBPα expression, which
were positively correlated with the H3K4 dimethylation.
The induced differentiation of adipocytes from hESCs pro-
vides an excellent model system to study the role of histone
demethylase LSD1 in the regulation of stem cell
Fig. 3 The LSD1 inhibitor CBB1007 increased H3K4me2 levels. a. The
expression levels of LSD1, histone H3, and H3K4me2 on day 14 after
induction were detected by Western blotting. In the control group to the
20-μM group, the expression of LSD1 and histone H3 decreased, where-
as the level of histone H3K4 dimethylation (H3K4me2) increased with
the increased dose of CBB1007. GAPDH was used as the internal stan-
dard. b. Densitometry analysis of the bands from the phosphorylated
forms of LSD1, histone H3 and H3K4me2. With increasing CBB1007
dose, LSD1 and histone H3 decreased together on day 14. However,
based on the demethylation role of LSD1, H3K4me2 increased and ex-
hibited an opposite expression tendency compared with LSD1. The re-
sults of the experiments were independently confirmed thrice. The error
bars represent SEMs for duplicate samples. The significant differences
were analyzed by one-way ANOVA.∗, P< 0.05
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differentiation. Based on our results, we conclude that the
LSD1inhibitor CBB1007 promotes the induced differentia-
tion of adipocytes from hESCs, and LSD1 may repress the
gene expression associated with adipogenic differentiation by
H3K4 demethylation.
In conclusion, our study demonstrates that the LSD1 inhib-
itor CBB1007 promotes the adipogenic differentiation of
hESCs through H3K4 methylation. Our work also sheds light
on the functional role and molecular mechanism of the histone
H3K4 demethylase LSD1 in the adipogenic differentiation of
hESCs.
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